Umban, Shirlyn A.

HRN: 29-08-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/11/2026
07/17/2026
IV
4.5g
Q6
Necrotizing Fasciitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines